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In the drug delivery formulation the choose of the carrier and of the procedure adopted for its 
synthesis is a determinant step. The investigations reported in literature deal with either 
polymeric materials [1] and/or inorganic oxides, such as nanoporous alumina, porous silica, 
nanostructured ceramics [2] and many synthetic approaches are available, among which: 
template method  [3] and sol-gel  [4]. Increasing attention has been recently devoted to titanium-
based drug delivery systems (DDS) [5, 6]. Titanium, titanium based alloys and TiO2 systems are 
among the most common implant materials (such as cardiovascular stents, joint replacements 
and dental implants) used in the human body because of their desirable mechanical strength, low 
density, excellent resistance to corrosion and lack of cytotoxic effects. Moreover,  titania features  
can be opportunely modulated by the wise selection of the synthetic approach. The addition of 
controlled drug delivery properties to the well known features of titanium-based materials could 
expand its potential applications in the biomedical field, and this represents a very attractive 
research outcome. The goal of this work was the development of a reliable procedure for the 
synthesis of nanostructured titania materials and its application in the design of titania-based 
drug delivery systems. A series of titanium oxides was prepared by a surfactant template method 
(STM) and used as carrier to sustain the release of ibuprofen, chosen as model drug. The STM 
procedure provides an efficient method to prepare TiO2 matrices with both high surface area (if 
compared with that obtained with the traditional synthetic approach) and a controlled 
nanoporous texture. Some parameters of the synthetic procedure were varied: pH, surfactant, 
ageing and calcination temperature. In particular, nanoporous matrices have been synthesized by 
using traditional surfactant [7] as: co-polymer (P-123) or ionic surfactant 
(hexadecyltrimethylammonium bromide) or  biocompatibles and biodegradables oligomers of 
natural origin, such as chitosan. In this last way it is possible to improve the final performance of 
DDS, or to increase their biocompatibility and/or biodegradability, to adjust the hydrophilicity 
and to introduce specific surfaces functionalities. The physico-chemical nature and the structure 
of the carriers has been investigated by means of N2 physisorption measurements, thermal 
analyses (TG/DTA), FT-IR analyses, transmission electron microscopy measurements (TEM), 
X-ray diffraction analysis; the drug delivery behaviour was tested in vitro in four different 
physiological solutions (simulating the gastro-intestinal tract) in order to analyze the behaviour 
of the TiO2-based systems if formulated as oral DDS. The synthetic parameters and in particular 
the nature of surfactant play a central role in directing the features of the TiO2 matrix and in the 
performance of the final DDS. The optimized approach turns out to be a good alternative to the 
classical methods employed to prepare efficient TiO2-based drug delivery systems.  
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